Dasatinib Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 20 mg, 50 mg, 70 mg, 100 mg, 140 mg
Reference Brands: Sprycel® (EU & US)
Category: Oncology Cancer Care
Dasatinib is an oral tyrosine kinase inhibitor for treating CML and ALL. Available in 20 mg, 50 mg, 70 mg, 100 mg, and 140 mg tablets, it is marketed as Sprycel® in the US and EU, offering key B2B opportunities in oncology.
Product Description:
Dasatinib is an oral tyrosine kinase inhibitor (TKI) used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). By targeting the BCR-ABL fusion protein, Dasatinib effectively blocks the signals that drive the growth of cancer cells. Available in tablet forms of 20 mg, 50 mg, 70 mg, 100 mg, and 140 mg, it offers a flexible dosing regimen for oncologists. Sprycel® (Dasatinib) is widely available in both the US and EU, providing essential treatment options for leukemia patients. This presents significant B2B opportunities for pharmaceutical manufacturers in these markets.
Dasatinib Tablet — third party manufacturing & bulk supply
Dasatinib Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Dasatinib Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Dasatinib Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Dasatinib Tablet →Frequently Asked Questions
Dasatinib is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+). It works by inhibiting abnormal tyrosine kinase activity, helping to control the growth of leukemia cells.
Dasatinib is made from the active pharmaceutical ingredient dasatinib, a tyrosine kinase inhibitor that targets BCR-ABL and other kinases involved in cancer cell proliferation.
It is marketed under the trade name Sprycel.
Dasatinib (Sprycel) is manufactured and marketed by Bristol-Myers Squibb.
The generic name is dasatinib.
Sprycel.
Dasatinib is manufactured in FDA-, EMA-, and MHRA-approved facilities for the USA, EU, UK, and other regulated markets.
Related Products
100% Water Soluble Curcumin
Strength:
500 mg, 1,000 mg
Form: Capsules
Reference Brands: Curcumin C3 Complex®, Theracurmin®, Meriva®(US); Curcumin Complex or Curcumin Phytosome.(EU)
View Details
Docetaxel 20 Mg Injection
Strength:
20 mg/1 mL, 80 mg/4 mL,160 mg/8 mL
Form: injection
Reference Brands: Docefrez (EU)
View Details
Cyclophosphamide
Strength:
Injection: 200 mg/2 mL (vial), 500 mg/5 mL (vial); Tablet: 25 mg, 50 mg ,100 mg
Form: Oral Tablet & Injection:
Reference Brands: Cytoxan®(US & EU), Endoxan®(EU)
View Details
Doxorubicin
Strength:
10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL (in vials)
Form: Injection
Reference Brands: Adriamycin® (EU & US)
View Details
Fludarabine Phosphate
Strength:
50 mg
Form: Injection
Reference Brands: Fludara (US/EU)
View DetailsGemcitabine
Strength:
200mg / 1 g / 1.4g
Form: Injection
Reference Brands: Gemzar (US/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
